Expansion of Overseas Mushroom Markets
First written in FY2016. 32 of 42 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-08-19.
45 other companies' latest entry also says "Advanced".
- FY2026Revenue growth and profit declineAnnual report
「As a result, total sales in the overseas mushroom business were ¥8,236 million, up 6.8% year on year, while segment profit was ¥1,147 million, down 0.8%.」
Sales in the overseas mushroom business increased 6.8%, partly due to the boost to yen-denominated sales from the weaker yen, while segment profit fell 0.8%. - FY2026-H1AdvancedAnnual report
「As a result, total sales in the overseas mushroom business were ¥3,827 million, up 6.7% year on year, while segment profit was ¥444 million, down 8.7%.」
Sales in the overseas mushroom business increased 6.7% year on year, indicating progress in market expansion on a sales basis. Meanwhile, segment profit fell 8.7%. - FY2025WorsenedAnnual report
「As a result, total sales in the overseas mushroom business were ¥7,711 million, down 2.2% year on year, while segment profit was ¥1,156 million, up 34.9%.」
Sales in the overseas mushroom business fell 2.2% year on year, indicating a setback in overseas market expansion on a sales basis. Meanwhile, segment profit increased 34.9%. - FY2025-H1WorsenedAnnual report
「As a result, total sales in the overseas mushroom business were ¥3,586 million, down 0.8% year on year.」
First-half sales in the overseas mushroom business fell 0.8% year on year, with overall results in overseas market expansion below the same period of the previous year. However, the disclosure also noted improvements in some regions through new customer acquisition and sales initiatives. - FY2024AdvancedAnnual report
「As a result, total sales in the overseas mushroom business were ¥7,887 million, up 20.8% year on year.」
Full-year sales in the overseas mushroom business increased 20.8% year on year, indicating measurable progress in overseas market expansion. However, some regions continued to fall short of plan. - FY2024-Q3AdvancedAnnual report
「As a result, total sales in the overseas mushroom business were ¥5,522 million, up 16.6% year on year.」
Cumulative third-quarter sales in the overseas mushroom business increased 16.6% year on year, indicating measurable progress in overseas market expansion. - FY2024-Q2AdvancedAnnual report
「As a result, total sales in the overseas mushroom business were ¥3,616 million, up 14.9% year on year.」
Cumulative second-quarter sales in the overseas mushroom business increased 14.9% year on year, indicating overall progress in overseas market expansion. - FY2024-Q1AdvancedAnnual report
「As a result, total sales in the overseas mushroom business were ¥1,657 million, up 7.8% year on year.」
First-quarter sales in the overseas mushroom business increased 7.8% year on year, indicating overall progress. However, some regions fell short of plan. - FY2023AdvancedAnnual report
「As a result, total sales in the overseas mushroom business were ¥6,530 million, up 2.9% year on year.」
Full-year sales in the overseas mushroom business increased 2.9% year on year. However, the US fell short of its profit plan, Taiwan fell slightly short of its sales plan, and Malaysia fell short of both its sales and operating profit plans. - FY2023-Q3AdvancedAnnual report
「As a result, total sales in the overseas mushroom business were ¥4,734 million, up 3.4% year on year.」
Cumulative third-quarter sales in the overseas mushroom business increased 3.4% year on year, indicating overall progress in overseas market expansion. However, some regions fell short of plan. - FY2023-Q2AdvancedAnnual report
「As a result, total sales in the overseas mushroom business were ¥3,148 million, up 9.5% year on year.」
Cumulative second-quarter sales in the overseas mushroom business increased 9.5% year on year, indicating overall progress in overseas market expansion. However, some regions fell short of plan. - FY2023-Q1AdvancedAnnual report
「As a result, total sales in the overseas mushroom business were ¥1,537 million, up 14.2% year on year.」
First-quarter sales in the overseas mushroom business increased 14.2% year on year, indicating overall progress in overseas market expansion. However, some regions fell short of plan. - FY2022AdvancedAnnual report
「As a result, total sales in the overseas mushroom business were ¥6,348 million, compared with ¥5,074 million in the previous fiscal year.」
Sales in the overseas mushroom business increased from ¥5,074 million in the previous fiscal year to ¥6,348 million. Sales expansion and cost measures were advanced in the US, Taiwan and Malaysia. - FY2022-Q3AdvancedAnnual report
「As a result, total sales in the overseas mushroom business were ¥4,577 million, compared with ¥3,491 million in the same quarter of the previous year.」
Sales in the overseas mushroom business increased from ¥3,491 million in the same quarter of the previous year to ¥4,577 million. The disclosure also noted shortfalls against sales and profit plans by region. - FY2022-Q2AdvancedAnnual report
「As a result, total sales in the overseas mushroom business were ¥2,875 million, compared with ¥2,172 million in the same quarter of the previous year.」
Sales in the overseas mushroom business increased from ¥2,172 million in the same period of the previous year to ¥2,875 million. The US and Taiwan exceeded plan, while Malaysia fell short of plan. - FY2022-Q1AdvancedAnnual report
「At the US subsidiary HOKTO KINOKO COMPANY, sales volume recovered as COVID-19 vaccination rates increased, and efforts to raise unit prices were strengthened. As a result, both sales and operating profit exceeded the previous year and the plan. Accordingly, total sales in the overseas mushroom business were ¥1,346 million, compared with ¥1,015 million in the same quarter of the previous year.」
Sales in the overseas mushroom business increased from ¥1,015 million in the same quarter of the previous year to ¥1,346 million. In the US, sales and operating profit exceeded the previous year and the plan, driven by the recovery in sales volume and higher unit prices. - FY2021WorsenedAnnual report
「As a result, total sales in the overseas mushroom business were ¥5,074 million, down 4.3% year on year.」
Full-year sales in the overseas mushroom business fell 4.3% year on year, and the results of overseas market expansion deteriorated. Meanwhile, expansion initiatives, including diversification of the customer portfolio and brand strengthening, continued. - FY2021-Q3WorsenedAnnual report
「As a result, total sales in the overseas mushroom business were ¥3,491 million, down 11.9% year on year.」
Cumulative third-quarter sales in the overseas mushroom business fell 11.9% year on year, and the results of overseas market expansion deteriorated. - FY2021-Q2WorsenedAnnual report
「As a result, total sales in the overseas mushroom business were ¥2,172 million, down 9.8% year on year.」
Cumulative second-quarter sales in the overseas mushroom business fell 9.8% year on year, indicating that deterioration due to COVID-19 and other factors was affecting the results of overseas market expansion. - FY2021-Q1WorsenedAnnual report
「As a result, total sales in the overseas mushroom business were ¥1,015 million, down 13.3% year on year.」
First-quarter sales in the overseas mushroom business fell 13.3% year on year, indicating that COVID-19-related deterioration was affecting the results of overseas market expansion. - FY2020AdvancedAnnual report
「As a result, sales in the overseas mushroom business were ¥5,301 million, up 4.1% year on year.」
Sales development and branding initiatives in the US, Taiwan and Malaysia lifted full-year sales in the overseas mushroom business by 4.1% year on year. - FY2020-Q3AdvancedAnnual report
「As a result, total sales in the overseas mushroom business were ¥3,963 million, up 6.3% year on year.」
As a result of developing non-Asian customers in the US, continuing stable trading with a major supermarket chain in Taiwan, and strengthening sales capabilities and expanding into Southeast Asia from Malaysia, overseas business sales increased 6.3% year on year. - FY2020-Q2AdvancedAnnual report
「HOKTO KINOKO COMPANY in the United States continued to focus on developing non-Asian customer markets and expanding sales, resulting in revenue exceeding the plan. In Taiwan, 台灣北斗生技股份有限公司 achieved revenue above the plan as strong sales channels and brand strength supported stable transactions and new customer development progressed smoothly. As a result, total revenue from the overseas mushroom business was ¥2.408 billion, up 3.1% year on year.」
New non-Asian customers were developed in the US, while stable trading and new customer acquisition progressed in Taiwan. Cumulative second-quarter sales in the overseas mushroom business increased 3.1% year on year. - FY2020-Q1AdvancedAnnual report
「HOKTO KINOKO COMPANY in the United States focused on developing non-Asian customer markets and expanding sales, resulting in revenue exceeding the plan. In Taiwan, 台灣北斗生技股份有限公司 achieved stable sales unaffected by external conditions through strong sales channels and brand strength despite a difficult sales environment for fresh produce overall, resulting in revenue exceeding the plan. As a result, total revenue from the overseas mushroom business was ¥1.171 billion, up 6.9% year on year.」
The company developed non-Asian customers in the United States, while strong sales channels and brand strength in Taiwan resulted in revenue exceeding the plan. Revenue from the overseas mushroom business rose 6.9% year on year. - FY2019AdvancedAnnual report
「As a result, total revenue from the overseas mushroom business was ¥5.092 billion, up 6.3% year on year.」
The company advanced efforts to develop non-Asian customers in the United States, conduct business with key supermarkets in Taiwan and expand sales in Southeast Asia, resulting in overseas business revenue rising 6.3% year on year. - FY2019-Q3AdvancedAnnual report
「HOKTO KINOKO COMPANY in the United States continued to focus on developing non-Asian customer markets and expanding sales. In Taiwan, 台灣北斗生技股份有限公司 focused on brand building, proposals and other initiatives in its sales activities. Sales initiatives with key supermarkets continued to perform well, supporting stable sales. As a result, total revenue from the overseas mushroom business was ¥3.727 billion, up 3.9% year on year.」
The company developed non-Asian customers in the United States and maintained stable sales with key supermarkets in Taiwan. Revenue from the overseas mushroom business rose 3.9% year on year. - FY2019-Q2AdvancedAnnual report
「HOKTO KINOKO COMPANY in the United States focused on developing non-Asian customer markets and expanding sales, resulting in higher revenue and profit than in the previous fiscal year. In Taiwan, 台灣北斗生技股份有限公司 focused on brand building, proposals and other initiatives in its sales activities. Sales initiatives with key supermarkets have been successful, enabling stable sales.」
Revenue and profit increased in the United States through the development of non-Asian customers, while stable sales became possible in Taiwan through initiatives with key supermarkets. Revenue from the overseas mushroom business rose 7.6% year on year. - FY2019-Q1AdvancedAnnual report
「In the overseas mushroom business, the sales environment for 台灣北斗生技股份有限公司 in Taiwan was difficult because of hot weather and low-priced products from competitors. However, the company successfully differentiated itself through active brand-building initiatives, including TV commercials, and proposals, resulting in higher revenue than in the previous fiscal year. HOKTO KINOKO COMPANY in the United States continued to focus on developing non-Asian customers and expanding sales, resulting in higher revenue than in the previous fiscal year. HOKTO MALAYSIA SDN. BHD. expanded sales not only in Malaysia but throughout the broader Southeast Asian market. Although the Singapore market performed well, sales of the company's products remained weak in other ASEAN markets due to competition from products made in China. In addition, the head office's overseas business division continued marketing activities in Asian countries and Europe to further expand distribution channels. As a result, total revenue from the overseas mushroom business was ¥1.096 billion, up 4.9% year on year.」
The company successfully differentiated itself in Taiwan through brand building and proposals, while revenue in the United States increased through the development of non-Asian customers. Revenue from the overseas mushroom business rose 4.9% year on year, although the impact of competing products from China remained in some ASEAN markets. - FY2018AdvancedAnnual report
「Production increased slightly as each overseas operation raised its capacity utilization. As a result, total revenue from the overseas mushroom business was ¥4.790 billion, up 6.2% year on year.」
Full-year revenue from the overseas mushroom business rose 6.2% year on year, mainly due to higher capacity utilization at overseas operations. - FY2018-Q3AdvancedAnnual report
「As a result, total revenue from the overseas mushroom business was ¥3.588 billion, up 8.1% year on year.」
Cumulative nine-month revenue from the overseas mushroom business rose 8.1% year on year, representing measurable progress in expanding overseas markets. - FY2018-Q2AdvancedAnnual report
「As a result, total revenue from the overseas mushroom business was ¥2.169 billion, up 22.9% year on year.」
Revenue from the overseas mushroom business rose 22.9% year on year, driven by higher capacity utilization at overseas subsidiaries, development of non-Asian customers in the United States, brand building in Taiwan, and expanded sales in Malaysia and Southeast Asia. - FY2018-Q1AdvancedAnnual report
「In the overseas mushroom business, production increased as the subsidiaries in the United States and Malaysia each raised their capacity utilization. In Taiwan, 台灣北斗生技股份有限公司 focused on brand building, proposals and other initiatives in its sales activities. In the United States, HOKTO KINOKO COMPANY focused on developing non-Asian customers and sought to expand sales. The company also continued its marketing activities in Europe. In Malaysia, HOKTO MALAYSIA SDN. BHD. expanded sales not only in Malaysia but throughout the broader Southeast Asian market. As a result, total revenue from the overseas mushroom business was ¥1.044 billion, up 21.7% year on year.」
Production increased as capacity utilization improved in the United States and Malaysia, while sales initiatives were advanced in Taiwan, the United States and Malaysia and marketing continued in Europe. Revenue from the overseas mushroom business rose 21.7% year on year. - FY2017AdvancedAnnual report
「As a result, total revenue from the overseas mushroom business was ¥4.512 billion, up 1.4% year on year.」
The company advanced efforts to improve capacity utilization and develop sales at its overseas subsidiaries, resulting in full-year revenue from the overseas mushroom business rising 1.4% year on year. - FY2017-Q3RestatedAnnual report
「In the overseas mushroom business, production increased as each subsidiary raised its capacity utilization.」
The company continued to report higher capacity utilization and increased production at its overseas subsidiaries. - FY2017-Q2AdvancedAnnual report
「In the overseas mushroom business, production increased as all of the subsidiaries in the United States, Taiwan and Malaysia raised their capacity utilization.」
Capacity utilization increased and production rose at all subsidiaries in the United States, Taiwan and Malaysia. - FY2017-Q1AdvancedAnnual report
「In the overseas mushroom business, production increased as the subsidiaries in the United States, Taiwan and Malaysia each raised their capacity utilization.」
The company reported higher capacity utilization and increased production at its operations in the United States, Taiwan and Malaysia. - FY2016First statedAnnual report
「While increasing capacity utilization, the company will focus on strengthening its brands and actively expand sales activities not only in each domestic market but also in neighboring countries, thereby expanding the mushroom market.」
The company aims to expand the markets of its operations in the United States, Taiwan and Malaysia by improving capacity utilization, strengthening its brands and increasing sales in neighboring countries.